首页 | 本学科首页   官方微博 | 高级检索  
检索        

网织红细胞参数在恶性肿瘤化疗前后的变化及临床意义
引用本文:陈瑞芬,黄丽芳,曾厚生,叶蔚兰,刘昊虹.网织红细胞参数在恶性肿瘤化疗前后的变化及临床意义[J].国际医药卫生导报,2014,20(8):1145-1147.
作者姓名:陈瑞芬  黄丽芳  曾厚生  叶蔚兰  刘昊虹
作者单位:陈瑞芬 (512000,韶关市第一人民医院检验科); 黄丽芳 (512000,韶关市第一人民医院检验科); 曾厚生 (512000,韶关市第一人民医院检验科); 叶蔚兰 (512000,韶关市第一人民医院检验科); 刘昊虹 (512000,韶关市第一人民医院检验科);
摘    要:目的 探讨网织红细胞参数在恶性肿瘤化疗前后的变化及临床意义.方法 选择我院2013年1月至12月收治的36例需行化疗的恶性肿瘤患者为研究对象,使用Sysmex XT-4000i全自动血液分析仪对比观察其化疗前后网织红细胞参数的变化情况,分析其临床意义.结果 患者在化疗后第7天时白细胞值(WBC)显著降低,到第14天时降到最低,差异具有统计学意义(P<0.05),到第21天时,WBC开始回升;而网织红细胞百分数(RET%)以及未成熟网织红细胞指数(IRF)在化疗后第7天时降到最低,差异具有统计学意义(P<0.05),在第14天时开始回升,到第21天时基本恢复到化疗前水平.结论 网织红细胞参数是一个较为敏感的指标,可用来评价恶性肿瘤患者化疗前后骨髓造血功能的抑制情况,值得临床推广.

关 键 词:恶性肿瘤  网织红细胞参数  化疗

Reticulocyte parameters before and after chemotherapy for malignant tumor
Chen Ruifen,Huang Lifang,Zeng Housheng,Ye Weilan,Liu Haohong.Reticulocyte parameters before and after chemotherapy for malignant tumor[J].International Medicine & Health Guidance News,2014,20(8):1145-1147.
Authors:Chen Ruifen  Huang Lifang  Zeng Housheng  Ye Weilan  Liu Haohong
Institution:Chen Ruifen, Huang Lifang, Zeng Housheng, Ye Weilan, Liu Haohong
Abstract:Objective To investigate the variation and clinical significance of reticulocyte parameters before and after the chemotherapy for malignant tumor.Methods 36 patients,admitted to our hospital from January to December,2013,needing chemotherapy,were selected as study objects.Sysmex XT4000i automated hematology analyzer was used to observe the change of reticulocyte parameters before and after the chemotherapy.Results The WBC values were significantly lower on day 7 after the chemotherapy and decreased to a minimum on day 14,with a statistical difference (P 〈 0.05).The WBC values bcgan to rise on day 21.The reticulocyte parameters and immature reticulocyte index decreased to a minimum on day 7,with statistical differences (P 〈 0.05).The reticulocyte parameters and immature reticulocyte index began to rise on day 14,and recovered to the levcl before chemotherapy on day 21.Conclusions Reticulocyte parameters is a sensitive indicator for evaluating the inhibition of bone marrow function before and after the chemotherapy and is worth being clinically generalized.
Keywords:Malignant tumor  Reticulocyte parameters  Chemotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号